Vax NK/HCC
Alternative Names: Autologous NK cells - Vaxcell Bio; Vax-NK/HCCLatest Information Update: 14 May 2024
At a glance
- Originator Vaxcell-Bio Therapeutics
- Class Antineoplastics; Immunotherapies; Natural killer cell therapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Liver cancer